TME Pharma Balance Sheet Health
Financial Health criteria checks 4/6
TME Pharma has a total shareholder equity of €1.6M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €2.9M and €1.4M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €2.70m |
| Equity | €1.57m |
| Total liabilities | €1.38m |
| Total assets | €2.94m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0N6A's short term assets (€2.9M) exceed its short term liabilities (€1.4M).
Long Term Liabilities: 0N6A has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 0N6A is debt free.
Reducing Debt: 0N6A currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0N6A has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0N6A has less than a year of cash runway if free cash flow continues to reduce at historical rates of 13.8% each year